Dimensional Fund Advisors’s Prime Medicine PRME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$40.8K Sell
13,362
-291,316
-96% -$968K ﹤0.01% 3201
2026
Q2
$1.12M Buy
304,678
+156
+0.1% +$518 ﹤0.01% 2844
2026
Q1
$1.06M Buy
304,522
+220,468
+262% +$839K ﹤0.01% 2831
2025
Q4
$292K Buy
+84,054
New +$374K ﹤0.01% 3047

Other funds holding PRME

Dimensional Fund Advisors's PRME Position: Q3 2026 in Review

Dimensional Fund Advisors reduced its Prime Medicine (PRME) stake by 96% in Q3 2026, selling an estimated $968K and leaving 13,362 shares worth $40.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3201.

Dimensional Fund Advisors first reported a position in PRME in Q4 2025 and has held it in 4 quarters since. The position peaked at $1.12M in Q2 2026. 187 funds tracked by Wall St. Rank hold PRME as of Q3 2026.

  • Dimensional Fund Advisors held 13,362 shares of Prime Medicine worth $40.8K as of Q3 2026.
  • Dimensional Fund Advisors sold 291,316 Prime Medicine shares in Q3 2026, an estimated $968K.
  • Prime Medicine made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q3 2026, its #3201 holding.
  • Dimensional Fund Advisors first reported a position in Prime Medicine in Q4 2025 and has held it in 4 quarters since.
  • Dimensional Fund Advisors's Prime Medicine position peaked at $1.12M in Q2 2026.
  • 187 funds tracked by Wall St. Rank held Prime Medicine as of Q3 2026.

Based on Dimensional Fund Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.